Rejoin™ PCR masterbatch for polyolefins ColorMatrix™ Optica™ Toners & Colors to correct and reduce yellowing and improve the quality of PET

We also offer a multitude of experience in manufacturing masterbatches suitable for compostability with the use of biodegradable and bio-based polymers.  As leaders in colorants and additives for PET packaging, we have extensive experience developing high-performance materials, colorants and additives for beverage containers and closures.

Colorant Chromatics™ Precolor and Masterbatch Formulations that counteract yellow tones without sacrificing heat and steam resistance Product description, value solution, key characteristics, target market, applications and technology benefits of ColorMatrix™ Lactra™ SX Light Blocking Additive for PET (English language version)

139209 TNA LLDPE MASTERBATCH 114194 BNA LLDPE MASTERBATCH 114195 BNA LDPE MASTERBATCH

193616 TNA LLDPE MASTERBATCH 183513 BKA LLDPE MASTERBATCH 183514 GYA LLDPE MASTERBATCH

147553 YE PE MASTERBATCH FDM 125-GN-20 GN TPU MASTERBATCH FDM 153-BU-20 BU TPU MASTERBATCH

Back Home // Products // Polymer Colorants // Solid Color Masterbatches // Mevopur™ Bio-based Polymer Solutions Mevopur Healthcare Bio-based Polymer Solutions are a unique offering of color and additive concentrates a.k.a masterbatches, and tailored ready-to-use solutions. In addition to bio-based polymer solutions, we can provide guidance on other masterbatches and formulations that can help increase the sustainability of your portfolio.

FDM UR 190066 TR YE PP MASTERBATCH FDM UR 185096 TR RD PP MASTERBATCH FDM UR 185098 PU PEARL PP MASTERBATCH

Avient and IVCC are creating a new masterbatch production laboratory in Guangzhou, China to support research and development of novel, active insecticide ingredients for long-lasting insecticidal treated nets (LLINs).  It will provide a medium-scale platform for testing and developing masterbatch formulations with insecticides to speed up the process of bringing LLINs to the market. With extensive global expertise in groundbreaking material solutions to support malaria control, Avient has the capabilities to optimize masterbatch formulations for LLINs to deliver ideal insecticide performance.

Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”). Q 2 2 0 2 1 P E R F O R M A N C E U P D AT E $69 $122 2020PF 2021 $0.42 $0.87 2020PF 2021 Q2 2021 – ORGANIC PERFORMANCE ( T O TA L C O M PA N Y ) 4 Sales Adjusted Operating Income $870 $1,235 2020PF 2021 + 42% Adjusted EPS + 77% + 107% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q2 2021 SEGMENT PERFORMANCE 5 CAI $488 $624 Sales ($ in millions) SEM Distribution $54 $86 Operating Income +28% +59% $239 $404 Sales $15 $24 Operating Income +69% +60% (1) $159 $241 Sales $17 $37 Operating Income +52% +118% (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 18.5% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 19.1% 2018 2019 2020 YTD 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 20.3% 2019 2020 YTD 2021 Legacy Clariant MB 11.9% 13.8% 16.8% 2019 2020 YTD 2021 • Synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive long-term revenue growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.